Drug Trial Radar · NCT00133848
Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment
Last checked: Nov 20, 2026Latest source record: Sep 23, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
210
Actual
Start
Apr 2005
Primary completion
Not stated
Study completion Jan 2006
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Aug 24, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 9 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to determine if topical SB-275833 ointment, 1% is more effective than a placebo ointment in the treatment of primary impetigo.
Conditions
- Impetigo
Interventions
SB-275833 ointment, 1%Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical response of impetigo at end of therapy visit. Clinical response of success is defined as no further need for antibacterial treatment.
Locations
22 sites in 5 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Bangalore, India
GSK Investigational Site
Hyderabad, India
GSK Investigational Site
Rome, Lazio, Italy
GSK Investigational Site
Mexico City, Mexico
GSK Investigational Site
Zapopan, Jalisco, Jalisco, Mexico
GSK Investigational Site
Beek en Donk, Netherlands
GSK Investigational Site
Deurne, Netherlands
GSK Investigational Site
Ermelo, Netherlands
GSK Investigational Site
Gouda, Netherlands
GSK Investigational Site
Musselkanaal, Netherlands
GSK Investigational Site
Musselkanaal, Netherlands
GSK Investigational Site
Nijmegen, Netherlands
GSK Investigational Site
Nijverdal, Netherlands
GSK Investigational Site
Roelofarendsveen, Netherlands
GSK Investigational Site
Rotterdam, Netherlands
GSK Investigational Site
Rotterdam, Netherlands
GSK Investigational Site
Soerendonk, Netherlands
GSK Investigational Site
Woerden, Netherlands
GSK Investigational Site
Zieuwent, Netherlands
GSK Investigational Site
Zwijndrecht, Netherlands
GSK Investigational Site
Lima, Peru
GSK Investigational Site
Callao, Provincia Constitucional del Callao, Peru
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.